The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines (Q46315417)

21 December 2017

title

The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines (English)

1 reference

21 December 2017

experimental autoimmune encephalomyelitis

main subject

inflammation

0 references

0 references

4

Hans-Peter Hartung

1 reference

21 December 2017

Patrick Vollmar

1

1 reference

21 December 2017

Stefan Nessler

series ordinal

2

1 reference

21 December 2017

Sudhakar Reddy Kalluri

series ordinal

3

1 reference

21 December 2017

Bernhard Hemmer

series ordinal

5

1 reference

21 December 2017

publication date

16 October 2008

1 reference

21 December 2017

The International Journal of Neuropsychopharmacology

published in

1 reference

21 December 2017

volume

12

1 reference

21 December 2017

issue

4

1 reference

21 December 2017

page(s)

525-536

1 reference

21 December 2017

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

The pharmacokinetics of venlafaxine when given in a twice-daily regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Effects of antidepressants on cytokine production and actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Hyperforin down-regulates effector function of activated T lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Physiology of psychoneuroimmunology: a personal view

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Effects of zimeldine and its metabolites, clomipramine, imipramine and maprotiline in experimental allergic neuritis in Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of 'depression due to multiple sclerosis'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Suppression of autoimmune encephalomyelitis by a neurokinin-1 receptor antagonist--a putative role for substance P in CNS inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

The immunoregulatory effects of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

The immunopathology of multiple sclerosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Depressive disorders and immunity: 20 years of progress and discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Astrocyte characterization in the multiple sclerosis glial scar

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen-specific interferon-gamma production in mouse EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

The T lymphocyte in experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Expanding the horizons of depression: beyond the monoamine hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

The neuropsychiatry of multiple sclerosis: a review of recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

7 January 2021

Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

7 January 2021

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

7 January 2021

Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

7 January 2021

Passive induction of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

7 January 2021

Therapeutic potential of phosphodiesterase type 4 inhibition in chronic autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

7 January 2021

Comparing the pathogenesis of experimental autoimmune encephalomyelitis in CD4−/− and CD8−/− DBA/1 mice defines qualitative roles of different T cell subsets

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

7 January 2021

Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

7 January 2021

Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells

1 reference

https://api.crossref.org/works/10.1017%2FS1461145708009425

7 January 2021

10.1017/S1461145708009425

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

18922202

1 reference

21 December 2017